Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Citric Acid | HCID 311 | — |
| Reactant | 1-Hydroxybenzotriazole | HCID 75771 | — |
| Reactant | 1,3-Propanediamine, N'-(ethylcarbonimidoyl)-N,N-dimethyl-, monohydrochloride | HCID 2723939 | — |
| Reactant | O-(tert-Butyldimethylsilyl)hydroxylamine | HCID 4691350 | — |
| Reactant | HCID 67056339 | HCID 67056339 | — |
| Solvent | Dimethylformamide | HCID 6228 | — |
| Product | HCID 50990949 | HCID 50990949 | 13.1% |
Reaction Steps
270 mg (2.0 mmol) of 1-hydroxybenzotriazole and 390 mg (2.0 mmol) of 1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide hydrochloride are added successively to a solution of 580 mg (1.7 mmol) of (S)-3-(4-but-2-ynyloxybenzoylamino)-2-piperidin-1-ylpropanoic acid in 15 ml of dimethylformamide. The reaction medium is stirred for 30 min at ambient temperature then 300 mg (2.0 mmol) of O-tert-butyldimethylsilylhydroxylamine in 5 ml of dimethylformamide are added. After stirring at ambient temperature for 18 h then hydrolysis with 2 ml of an aqueous solution of 5% citric acid, the reaction medium is stirred at ambient temperature for a further 30 min, then extracted with ethyl acetate. The ethyl acetate phase is washed with a saturated aqueous solution of sodium hydrogen carbonate then with a saturated aqueous solution of sodium chloride, dried over magnesium sulphate, filtered and concentrated. The residue obtained is purified by chromatography over silica gel eluted with a 98/2 dichloromethane/methanol mixture. 80 mg (13%) of 4-but-2-ynyloxy-N—((S)-2-hydroxycarbamoyl-2-piperidin-1-ylethyl)benzamide are obtained in the form of a white solid having a melting point of 144° C.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US09266848B2 |
|---|
| Source dataset | uspto-grants-2016_02 |
|---|
| ORD ID | ord-5bcf9ee10b2146aaa11d2a4773a206a3 |
|---|
| Source note | uspto-grants-2016_02 |
|---|